From long waiting times to a lack of trained professionals, it is high time that policymakers stood up to do more to help patients with skin conditions
From expansive artificial intelligence programming to nano-engineering, dermatology is at the cutting edge of the digital health revolution
Rare disease patients in developing countries and rural regions are often neglected, and in need of diagnosis backed up by treatment and research
Incredibly uncommon and hard to diagnose and treat, how can we advance the treatment of ultra-rare diseases if there are still so many unknowns?
Current methods to determine the right value for orphan drugs remain controversial, yet the fast-tracking of new therapies marks a big step forward for the industry
‘If we embrace our genomic future, we stand to transform the prospects for diagnosis and treatment of rare and common diseases alike’
Searching for new ways to help people manage chronic pain has become the Holy Grail for the pharmaceutical industry
Although there have been many dramatic breakthroughs in chemotherapy, often guided by genomics, in immunotherapy, radiotherapy and surgery, there are still many cancer patients who progress in spite of these advances